Acumen Pharmaceuticals Inc.

ABOS | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.59

-$0.06 (-2.26%)

At close: Sep 21, 2026, 4:00 PM ET

$2.60

+$0.01 (+0.53%)

Pre-market: Sep 22, 2026, 5:37 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.26%

(1D)

Rating

Updated: Aug 24, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $187.07M

1D Range

2.56 2.65

52W Range

1.22 3.60

Valuation (TTM)

PE -1.58

PB 3.27

EV/EBITDA -1.08

Valuation (NTM)

Forward PE N/A

Forward PEG 0.49

Price Target $7

Cash Flow

FCF Yield -49.1%

SBC Adj. FCF Yield -54.3%

SBC Impact -10.7%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -15.8% | -21.0%

FCF 3Y | 5Y -20.4% | -31.0%

Returns

ROA -90.5%

ROE -136.3%

ROIC -118.6%

Financial Health

Net Cash

$78.63M

Current Ratio 2.47

Interest Coverage -24.41

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus ...

Sector Healthcare

Industry Biotechnology

Employees 61

IPO Date Jun 30, 2021

Website acumenpharm.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

Upside

+170.27%

Buy (3)

Hold (0)

Sell (0)

Analyst Details ➞